Nigeria Cuts Malaria Cases in Half Since 2010

After years of aggressive action against one of Africa's deadliest diseases, Nigeria is finally winning the fight against malaria.

The World Health Organization announced that malaria rates in Nigeria have dropped from 42% in 2010 to 22% in 2021, with recent data showing the decline continues. For a country of over 200 million people, that translates to millions of lives protected from a disease that once threatened nearly half the population.

Dr. Lynda Ozor, WHO's Malaria Programme Manager, credits the turnaround to a coordinated national effort. Wider distribution of insecticide-treated bed nets, improved treatment access, and expanded prevention programs for children during peak malaria season are all contributing to measurable results across the country.

Nigeria began rolling out a malaria vaccine in 2024, starting in Kebbi and Bayelsa states, with Bauchi recently joining. The vaccine requires four doses given through routine childhood immunizations, offering protection when children are most vulnerable.

Concerns about vaccine safety were directly addressed by WHO officials. Dr. Ozor explained that the RTSS malaria vaccine underwent 34 years of research and extensive testing before approval. Nigeria's own drug regulatory authority conducted independent safety reviews before allowing its use.

She dismissed claims about harmful effects as misinformation spread by anti-vaccine groups. The vaccine's side effects are minimal, similar to other routine medications, and most communities have welcomed its arrival after decades of waiting for this tool.

The Ripple Effect

The progress against malaria means more than just health statistics. Fewer sick children means more kids in school and parents at work instead of at hospital bedsides. Communities once devastated by seasonal malaria outbreaks are seeing their youngest members grow up healthier and stronger.

The Federal Government, state authorities, and international partners continue expanding the vaccine program while maintaining the prevention efforts that started the decline. Dr. Kolawole Maxwell of Malaria Consortium emphasized that the vaccine only works if it reaches every eligible child, which is why teams are exploring creative ways to connect with caregivers.

The phased rollout allows health officials to learn what works best before expanding nationwide. Initial coverage fell below expectations, prompting the launch of the Enhance Project to improve vaccine uptake by working with existing malaria prevention teams who already have community trust.

Nigeria's example proves that even massive public health challenges can be overcome with sustained commitment, smart strategy, and community participation working together toward elimination.